Blocking of TNF-α and IL-1 inhibits leukocyte infiltration at early, but not at late stage of S. aureus-induced arthritis and the concomitant cartilage destruction in rabbits

Clinical Immunology and Immunopathology

Volumn 82, Issue 1, 1997, Pages 18-25

  Kimura, Makoto ^a   Matsukawa, Akihiro ^a   Ohkawara, Susumu ^a   Takagi, Katsumasa ^a   Yoshinaga, Masaru ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MONOCLONAL ANTIBODY; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTICULAR CARTILAGE; BACTERIAL ARTHRITIS; CONTROLLED STUDY; FEMALE; LEUKOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS;

EID: 0031015036     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4276     Document Type: Article

References (45)

1. 1. Shulman, G., and Waugh, T. R., Acute bacterial arthritis in the adult. Orthop. Rev. 17, 955-960, 1988.
2. 2. Kelly, P. J., Martin, W. J., and Coventry, M. B., Bacterial (suppurative) arthritis in the adult. J. Bone Joint Surg. 52A, 1595-1602, 1970.
3. 3. Goldenberg, D. L., and Reed, J. I., Bacterial arthritis. N. Engl. J. Med. 312, 764-771, 1985.
4. 4. Koga, T., Kakimoto, K., Hirofuji, T., Kotani, S., Sumiyoshi, A., and Saisho, K., Muramyl dipeptide induces acute joint inflammation in the mouse. Microbiol. Immunol. 30, 717-723, 1986.
5. 5. Onta, T., Sashida, M., Fujii, N., Sugawara, S., Rikiishi, H., and Kumagai, K, Induction of acute arthritis in mice by peptidoglycan derived from gram-positive bacteria and its possible role in cytokine production. Microbiol. Immunol. 37, 573-582, 1993.
6. 6. Dinarello, C. A., The biology of interleukin-1. Chem. Immunol. 51, 1-32, 1992.
7. 7. Tracey, K. J., Tumor necrosis factor-Alpha. In "The Cytokine Handbook," 2nd ed., pp. 289-304, 1994.
8. 8. Ramilo, O., Saez, L. X., Mertsola, J., Jafari, H., Olsen, K. D., Hansen, E. J., Yoshinaga, M., Ohkawara, S., Nariuchi, H., and McCracken, G. H., Tumor necrosis factor-α/cachectin and interleukin-1β initiate meningeal inflammation. J. Exp. Med. 172, 497-507, 1990.
9. 9. Matsukawa, A., Ohkawara, S., Maeda, T., Takagi, K., and Yoshinaga, M., Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin. Exp. Immunol. 93, 206-211, 1993.
10. 10. Edamitsu, S., Matsukawa, A., Ohkawara, S., Takagi, K., Nariuchi, H., and Yoshinaga, M., Role of TNFα, IL-1, and IL-1ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. Clin. Immunol. Immunopathol. 75, 68-74, 1995.
11. 11. Casey, L. C., Balk, R. A., and Bone, R. C., Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119, 771-778, 1993.
12. 12. Wolf, R. E., Brelsford, W. G., Hall, V. C., and Adams, S. B., Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis. J. Rheumatol. 19, 524-528, 1992.
13. 13. Williams, R. O., Feldmann, M., and Maini, R. N., Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89, 9784-9788, 1992.
14. 14. Dinarello, C. A., and Thompson, R. C., Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12, 404-410, 1991.
15. 15. van, d. B. W., Joosten, L. A., Helsen, M., and van, d. L. F., Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95, 237-243, 1994.
16. 16. Fisher, C. J., and Dhainaut, J. F. A. (Eds.), Recombinant interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomised, double-blind, placebo-controlled trial. J. Am. Med. Assoc. 271, 1836-1843, 1994.
17. 17. Arend, W. P., and Dayer, J. M., Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38, 151-160, 1995.
18. 18. Antin, J. H., and Weinstein, H. J. (Eds.), Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood 84, 1342-1348, 1994.
19. 19. Haranaka, K., Satomi, N., Sakurai, A., and Nariuchi, H., Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int. J. Cancer 36, 395-400, 1985.
20. 20. Matsukawa, A., Mori, S., Ohkawara, S., Maeda, T., Tanase, S., Edamitsu, S., Yanagi, F., and Yoshinaga, M., Production, purification and charactalization of a rabbit recombinant IL-1 receptor antagonist. Biomed. Res. 13, 269-277, 1992.
21. 21. Kawabata, K., Suzuki, M., Sugitani, M., Imaki, K., Toda, M., and Miyamoto, T., ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem. Biophys. Res. Commun. 177, 814-820, 1991.
22. 22. Farndale, R. W., Buttle, D. J., and Barrett, A. J., Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem. Biophys. Acta 883, 173-177, 1986.
23. 23. Flick, D. A., and Gifford, G. E., Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68, 167-175, 1984.
24. 24. Matsukawa, A., Furukawa, S., Ohkawara, S., Takagi, K., and Yoshinaga, M., Development of a neutralizing monoclonal antibody against rabbit IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Immunol. Invest. 23, 129-142, 1994.
25. 25. Wedmore, C. V., and Williams, T. J., Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289, 646-650, 1981.
26. 26. Humphrey, J. H., The mechanism of Arthus reactions. I. The role of polymorphonuclear leukocytes and other factors in reversed passive Arthus reactions in rabbits. Br. J. Exp. Pathol. 36, 268-282, 1951.
27. 27. Malawista, S. E., Gouty inflammation. Arthritis Rheum. 20, S241-248, 1977.
28. 28. Weissmann, G., and Korchak, H., Rheumatoid arthritis. The role of neutrophil activation. Inflammation 8, S3-14, 1984.
29. 29. Saez, L. X., Jafari, H. S., Olsen, K. D., Nariuchi, H., Hansen, E. J., and McCracken, G. H., Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-α, and interleukin-1 β. J. Infect. Dis. 163, 1267-1272, 1991.
30. 30. Jafari, H. S., Saez-Llorens, X., Paris, M., Rinderknecht, S., Friedland, I., Ehrett, S., Severien, C., Olsen, K. D., Burns, D. K., Harper, C. F., Lark, M. W., Thonar, E. J.-M. A., and McCracken, G. H., Dexamethasone attenuation of cytokine-mediated articular cartilage degeneration in experimental lapine Haemophilus arthritis. J. Infect. Dis. 168, 1186-1193, 1993.
31. 31. Leonard, E. J., and Yoshimura, T., Neutrophil attractant/activation protein-1 (NAP-1 (interleukin-8)). Am. J. Respir. Cell. Mol. Biol. 2, 479-486, 1990.
32. 32. Baggioni, M., Dewald, B., and Moser, B., Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55, 97-179, 1994.
33. 33. Matsukawa, A., Yoshimura, T., Maeda, T., Ohkawara, S., Takagi, K., and Yoshinaga, M., Neutrophil accumulation and activation by homologous IL-8 in rabbits: IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J. Immunol. 154, 5418-5425, 1995.
34. 34. DeForge, L. E., Kenney, J. S., Jones, M. L., Warren, J. S., and Remick, D. G., Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J. Immunol. 148, 2133-2141, 1992.
35. 35. Wilbrink, B., Nietfeld, J. J., den, O. W., van, R. J., Bijlsma, J. W., and Huber, B. O., Role of TNFα, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br. J. Rheumatol. 30, 265-271, 1991.
36. 36. Saklatvala, J., Pilsworth, L. M., Sarsfield, S. J., Gavrilovic, J., and Heath, J. K., Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem. J. 224, 461-466, 1984.
37. 37. Pettipher, E. R., Henderson, B., Moncada, S., and Higgs, G. A., Leucocyte infiltration and cartilage proteoglycan loss in immune arthritis in the rabbit. Br. J. Pharmacol. 95, 169-176, 1988.
38. 38. Williams, R. 3., Smith, R. L., and Schurman, D. J., Purified staphylococcal culture medium stimulates neutral metalloprotease secretion from human articular cartilage. J. Orthop. Res. 9, 258-265, 1991.
39. 39. Janusz, M. J., and Hare, M., Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines. A model of metalloproteinase-mediated connective tissue degradation. J. Immunol. 150, 1922-1931, 1993.
40. 40. Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H., Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721-730, 1990.
41. 41. Okada, Y., Shinmei, M., Tanaka, O., Naka, K., Kimura, A., Nakanishi, I., Bayliss, M. T., Iwata, K., and Nagase, H., Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab. Invest. 66, 680-690, 1992.
42. 42. Arend, W. P., Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88, 1445-1451, 1991.
43. 43. Miller, L. C., Lynch, E. A., Isa, S., Logan, J. W., Dinarello, C. A., and Steere, A. C., Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341, 146-148, 1993.
44. 44. Malyak, M., Swaney, R. E., and Arend, W. P., Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils. Arthritis Rheum. 36, 781-789, 1993.
45. 45. Casini, R. V., Kam, L., Chong, Y. J., Fiocchi, C., Pizarro, T. T., and Cominelli, F., Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J. Immunol. 154, 2434-2440, 1995.